baber/WOPTO huggingface dataset:
Patent NZ-517326-A (NZ)
Title: Internet cache on a wireless base station
Inventor: MADSEN JAMES S
IPC: G06F17/30
Filed: 2000-09-01
Abstract: In a wireless system comprising a plurality of radio base station, each base station services a portion of the system. A cache is associated with each base station. The cache stores files regularly requested by the remote unit within the coverage area of the corresponding base station. When a base station receives a message from a remote unit, it parses the message to determine if the message comprises a file request. If so, the base station determines whether the file is available from the cache. If available, the base station responds to the request by forwarding the requested file from the cache. If the file is not available, the base station forwards the message to a central controller, which retrieves the file via the Internet from the appropriate content server and provides it to the base station.
Patent NZ-523627-A (NZ)
Title: HMG-CoA reductase inhibitors and method
Inventor: ROBL JEFFREY A
IPC: A61P9/10
Filed: 2001-06-12
Abstract: A compound of formula (I); a pharmaceutical composition comprising the compound; and the use of the compound in the preparation of a medicament for inhibiting cholesterol biosynthesis or lowering blood serum cholesterol levels and/or modulating blood serum cholesterol levels, lowering LDL cholesterol and/or increasing HDL cholesterol, or treating dyslipidemia, mixed dyslipidemia, LDL Pattern B, LSL Pattern A, hyperlipidemia, hypercholesterolemia, hypo á-lipoproteinemia, hyperlopoproteinemia or hypertriglyeridemia, and other aberrations of apolipoprotein B metabolism, or reducing levels of Lp(a), or treating or preventing other cholesterol-related disease, or treating or preventing or reversing progression of atherosclerosis, or preventing or treating Alzheimer's disease, osteoporosis and/or osteopenia, or reducing inflammatory markers, reducing C-reactive protein, or preventing or treating low grade vascular inflammation, stroke, dementia, coronary heart disease, primary and secondary prevention of myocardial infarction, or preventing or treating stable and unstable angina, or primary prevention of coronary events, or secondary prevention of cardiovascular events, or preventing or treating peripheral vascular disease or peripheral arterial disease, acute vascular syndromes, preventing or reducing the risk of undergoing myocardial revascularisation procedures or preventing or treating microvascular diseases such as nephropathy, neuropathy, retinopathy and nephritic syndrome, or preventing or treating hypertension, type I diabetes, type II diabetes and related diseases, insulin resistance, hyperglycemia, hyperinsulinemia, elevated blood levels of fatty acids or glycerol, obesity, LDL complications, dysmetabolic syndrome and related diseases, and sexual dysfunction, preventing and treating malignant lesions, premalignant lesions, gastrointestinal induced asthenia (fatigue), irritable bowel syndrome, Crohn's disease, gastric ulceritis and gallstones, HIV infection, drug-induced lipodystrophy and proliferative diseases, improving coagulation homeostasis, reducing PAI-1 activity, reducing fibrinogen, and/or reducing platelet aggregation and/or improving endothelial function.
Patent NZ-523662-A (NZ)
Title: Modified botulinum neurotoxin with a leucine based motif
Inventor: STEWARD LANCE E
IPC: A61P37/00
Filed: 2001-07-20
Abstract: A modified neurotoxin comprises a botulinum neurotoxin having a structural modification wherein the modification is effective to alter the biological persistence of the modified neurotoxin relative to a neurotoxin without the modification and comprises a leucine based motif of SEQ ID NO: 2 (XEXXXLL) that is deleted when the biological persistence is reduced and is added when the biological persistence is enhanced. Preferably the leucine based motif is FEFYKLL. The modified neurotoxin is useful for treating neuromuscular disorders, autonomic disorders and pain.
Patent NZ-528159-A (NZ)
Title: Rotary piston machine for compressible media
Inventor: BECHER ULRICH
IPC: F04C23/00
Filed: 2002-02-25
Abstract: Rotary piston machine for compressible media, with rotary pistons sealed tight in a common housing and rotatable with one another in a controlled manner, the rotary pistons having a plurality of disk-shaped sections engaging in one another in pairs, whose thickness and/or diameter decreases in the direction of the pressure side, each disk having a surface area and a core area connected respectively by an interface area, the sector angles of the surface area and of the core area of a respective disk not being identical, the disks having various transverse profile contours periodically recurring along the piston axes and each disk being offset at an angle to the two adjacent disks of the same rotor in a such a way that these three disks have a common area section and form a chamber.
Patent NZ-528190-A (NZ)
Title: Cheese making process
Inventor: DAMBMANN CLAUS
IPC: A23C19/032
Filed: 2002-03-21
Abstract: Disclosed is a process for making cheese comprising: a) adding to a milk a carbohydrase for deglycosylation of kappa-casein , selected from the group consisting of alpha-galactosidase, N-acetyl-galactosaminidase and neuraminidase; b) incubating so as to partially deglycosylate with the carbohydrase kappa-casein in the milk; c) during of after step b) using the deglycosylation of kappa-casein to initiate the coagulation.
Patent NZ-529309-A (NZ)
Title: Broadcast spreader with movable deflector
Inventor: COURTNEY STEVE P
IPC: E01C19/20
Filed: 2002-04-29
Abstract: Disclosed is a spreader for broadcasting particulate materials in a controlled pattern of distribution comprising a container for holding the material to be dispensed, means connected to the container for facilitating movement of the container in a direction for travel, a rotatable plate mounted to the container for receiving dispensed material from the container and for distributing the material, a mechanism for rotating the plate, a deflector connected to the container for controlling the distribution of the material, the deflector being movable about the plate, a track attached to the container for supporting the deflector, a port disposed between the container and the plate for passing dispensed material and a port closure element connected to and movable with the deflector for selectively blocking the port.
Patent NZ-531029-A (NZ)
Title: Steerable load-carrying assemblies
Inventor: BIDWELL ALAN LESLIE
IPC: B62B3/00
Filed: 1998-03-30
Abstract: Apparatus for controlling the direction of travel of a steerable assembly. The apparatus includes: (i) a first member (203) associated with a tie-rod (202) operably connected to one or more steerable wheels of the assembly; (ii) two further members (205, 206) associated with a fixed chassis member (201) of the assembly, each of the further members being selectively and continuously pivotably movable relative to the fixed chassis member between respective inoperative and operative positions; and (iii) resilient means (209) associated with the further members. The arrangement is such that, in use, when the steerable wheels of the assembly undergo a change in direction, the first member and one of the further members come into contact, whereby the resilient means acts to return the further member to its inoperative position, thereby correcting the steering of the assembly. (62) Divided out of 521312
Patent NZ-531724-A (NZ)
Title: Oxygen-absorbing, multilayered, free flowing granulate with high and long-lasting oxygen absorption capacity
Inventor: BRANDSCH RAINER
IPC: B65D81/26
Filed: 2002-08-27
Abstract: An oxygen absorbing granulate that has a non-homogenous structure comprises: (a) a core region, containing a substrate for an oxygen-removing enzyme, as well as optionally at least one binder; and (b) a shell at least partially surrounding the core region (a), containing an oxygen removing enzyme or enzyme mixture. Methods for production of the oxygen absorbing granulate as defined above are also described. The oxygen-absorbing granulate can be used for the protection of oxygen-sensitive products from sectors such as electronics and pharmaceuticals and can be used in a flexible or shape-stable container with at least one gas-permeable wall.
Patent NZ-532160-A (NZ)
Title: Method for obtaining cobalt and nickel from ores and ore concentrates
Inventor: BECKMANN ALEXANDER
IPC: C22B1/06
Filed: 2002-09-14
Abstract: Disclosed is a process for extracting metals from an arsenosulfidic and/or sulfidic cobalt and/or nickel ore or ore concentrate in which the arsenosulfidic and/or sulfidic cobalt and/or nickel ore or ore concentrate is converted to a reaction product containing CoS and/or NiS by sulphur of sulphur-containing arsenic compounds; and soluble metals and rare earth metals are leached from the reaction product.
Patent NZ-534845-A (NZ)
Title: Method of treating mucositis with an anti-fungal and an anti-bacterial agent
Inventor: BORODY THOMAS JULIUS
IPC: A61P31/10
Filed: 2003-01-24
Abstract: Disclosed is a pharmaceutical composition for the systematic administration for the treatment of respiratory tract mucositis. The composition comprises therapeutically effective amounts of at least one anti-fungal agent and two or more anti-bacterial agents. The anti-fungal agents are described to include flucytosine, ketoconazole, miconazole, olamine and proprionic acid. The anti-bacterial agents belong to one or more of the classes of tetracyclines, penicillins, macrolides, quinolones, chloramphenicol, rifamycins, sulphonamides, co-trimoxazole, and oxazolidinones.
Patent NZ-535503-A (NZ)
Title: Fastening cross-arm to utility pole using clamping
Inventor: KRALIC JOHN FRANK
IPC: H01Q1/12
Filed: 2003-06-22
Abstract: Cross-arm 5 is attached to utility pole 4 by a saddle 6 of "flanged U shape". Bolts 9 engage cross-arm 5 so as to clamp the cross-arm to the pole when tightened.
Patent NZ-537777-A (NZ)
Title: Waterproof and breathable sole for shoes
Inventor: POLEGATO MORETTI MARIO
IPC: A43B9/00
Filed: 2003-07-07
Abstract: Waterproof and breathable sole for shoes, having a structure that comprises: a mid-sole component (10, 110) with a membrane (11, 111) made of a material that is impermeable to water and permeable to water vapor and is connected in spots with a lower protective layer (14, 114) made of a material that is resistant to hydrolysis, water-repellent, breathable and/or perforated; a tread (15, 115) made of perforated elastomer that is joined perimetrically and hermetically to the component (10, 110); said membrane (11, 111) being associated with said protective layer (14, 114) by way of a thermoreactive adhesive (13, 113).
Patent NZ-538259-A (NZ)
Title: Methods and compositions for production of flavonoid and isoflavonoid nutraceuticals
Inventor: DIXON RICHARD A
IPC: C12N15/82
Filed: 2003-09-10
Abstract: Disclosed is a method of increasing isoflavonoid biosynthesis in a plant comprising: a) down-regulating flavanone 3-hydroxylase in the plant; and b) up-regulating isoflavone synthase and/or production of liquiritigenin or naringenin in the plant.
Patent NZ-539205-A (NZ)
Title: Therapeutic piperazine compounds
Inventor: SUN QUN
IPC: A61P29/00
Filed: 2003-09-24
Abstract: Disclosed are piperazine compounds of formula (I), (II), (III) or (IV) wherein the substituents are as described. Compounds of the type disclosed are useful for inhibiting VR1 function in a cell, in particular for the treatment of pain.
Patent NZ-540237-A (NZ)
Title: Liquid storage assembly
Inventor: GORDON MALCOLM BRUCE
IPC: E03B3/03
Filed: 2003-12-03
Abstract: A liquid storage assembly (1) comprising, a liquid delivery conduit (3), an expandable liquid storage container (6) arranged to receive liquid from the liquid delivery conduit (3), and bypass means (9) arranged to direct liquid from the liquid delivery conduit away from the expanadable liquid storage container when it has attained a predetermined degree of expansion.
Patent NZ-540381-A (NZ)
Title: 5-membered aromatic heterocycle derivatives as prophylactic and therapeutic agents for treating neuropathy
Inventor: MOMOSE YU
IPC: A61K31/427
Filed: 2003-10-30
Abstract: The present disclosure provides an agent of formula (II) for preventing or treating neuropathy having superior action and low toxicity, wherein: ring A is a 5-membered aromatic heterocycle containing 2 or more nitrogen atoms, which may further have substituent (s); B is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group; X is a divalent acyclic hydrocarbon group; Z is -O-, -S-, -NR2-, -CONR2- or -NR2CO- (R2 is a hydrogen atom or an optionally substituted alkyl group); Y and Y1 are the same or different and each is a bond or a divalent acyclic hydrocarbon group; and D is a ring optionally further having substituent (s); R3 is an optionally substituted acyl group or an optionally substituted heterocyclic group, provided that when the 5-membered aromatic heterocycle represented by ring A is imidazole, then Z should not be -O- and provided that when the 5-membered aromatic heterocycle represented by ring A is pyrazole, X is methylene, Z is -S- and Y is a bond, then the ring represented by D should not be oxadiazole, or a salt thereof.
Patent NZ-542340-A (NZ)
Title: Riding saddle
Inventor: KEMPSELL DAVID
IPC: B68C1/04
Filed: 2003-04-16
Abstract: A saddle tree 100 comprises a tree body having a pommel end and a cantle end. The tree body is formed from a flexible material and a generally Y-shaped strengthening bar 123. Forks of the Y-shaped bar 123 are directed towards the cantle end. The bar 123 may be made from carbon fibre, the pommel end of the saddle tree may be angularly adjustable and a head plate 121 may be located near the pommel end.
Patent NZ-542711-A (NZ)
Title: Acetylene derivatives as inhibitors of histone deacetylase
Inventor: SENDZIK MARTIN
IPC: C07D261/08
Filed: 2004-08-19
Abstract: Disclosed are hydroxamate derivatives of formula (I) that are inhibitors of histone deacetylase and therefore useful in the treatment of diseases associated with histone deacetylase activity, such as cancer. Pharmaceutical compositions and processes for preparing these compounds are also disclosed.
Patent NZ-545445-A (NZ)
Title: Process for the purification of terbinafine
Inventor: BEUTLER ULRICH
IPC: C07C209/84
Filed: 2004-08-27
Abstract: Disclosed is a process for the purification of terbinafine of Formula 1, which comprises subjecting crude terbinafine, in free base form, to distillation at a temperature above 100 degrees Celsius and under reduced pressure, and recovering the purified product in free base or acid salt form.
Patent NZ-546218-A (NZ)
Title: 4-Piridinylmethylsulphonamide derivatives as fungicidal plant protection agents
Inventor: GRAMMENOS WASSILIOS
IPC: C07D215/12
Filed: 2004-09-10
Abstract: Disclosed are 4-piridinylmethylsulfonamide derivatives of the formula I wherein the substituents are defined within the specification. Also disclosed is a method of controlling phytopathogenic harmful fungi, which comprises treating the fungi or the materials, plants, the soil or seeds to be protected against fungal attack with an effective amount of the above compounds of formula I.
Patent NZ-549838-A (NZ)
Title: Coated controlled-release preparation containing a gastric acid secretion inhibitor
Inventor: YOSHITAKE TAKASHI
IPC: A61K9/14
Filed: 2005-03-23
Abstract: Disclosed is a controlled-release pharmaceutical composition, comprising: A) a core containing a benzimidazole-based acid-unstable physiologically active substance (such rabeprazole, omeprazole, pantoprazole, lansoprazole or esomeprazole, or a physiologically acceptable salt thereof); a disintegrant selected from the group consisting of crospovidone, low-substituted hydroxypropyl cellulose, croscarmellose sodium, and carmellose calcium; an alkaline additive selected from the group consisting of sodium hydroxide, potassium hydroxide, magnesium oxide, calcium oxide, magnesium hydroxide, and calcium hydroxide; B) a release-controlling coating which covers the core, and which contains a water-insoluble polymer, selected from the group consisting of ethyl cellulose, an aminoalkyl methacrylate copolymer RS and shellac; an enteric polymer selected from the group consisting of hydroxypropyl methyl cellulose phthalate, hydroxypropyl methyl cellulose acetate succinate, a methacrylic acid-methyl methacrylate copolymer, and a methacrylic acid-ethyl acrylate copolymer; and a hydrophobic wax, wherein an amount of the hydrophobic wax in the release-controlling coating is 20 to 30 wt%, based on the weight of the release controlling coating.
Patent NZ-550746-A (NZ)
Title: Portable data storage device with encryption system
Inventor: OOI CHIN SHYAN RAYMOND
IPC: H04L9/00
Filed: 2004-04-26
Abstract: A portable data storage device has a non-volatile memory (3) for storing user data, an interface section (7) for receiving and transmitting data to a host, and a master control unit (1) for transferring data to and from the non-volatile memory (3). The portable data storage device further includes an integrated circuit (13) for generating at least one key. The portable data storage device is arranged, upon receiving a command from a host requesting data, to transmit the requested data stored in its memory to the host using the interface section and to transmit at least one of the keys generated by the integrated circuit means to the host using the interface section. The device is further arranged to generate and transmit to the host or to receive from the host a digital signature using the generated key and the requested data for use in verifying that the requested data has been correctly received by the host.
Patent NZ-551027-A (NZ)
Title: Benzotriazine inhibitors of kinases
Inventor: NORONHA GLENN
IPC: A61K31/53
Filed: 2005-04-07
Abstract: Disclosed are 3-aminoarylene-1,2,4-benzotriazine derivatives of the general formula (I), which are useful compounds for the treatment of disorders associated with compromised vasculostasis (such as myocardial infarction, stroke, congestive heart failure, an ischemia or reperfusion injury, cancer, arthritis or other arthropathy, retinopathy or vitreoretinal disease, macular degeneration, autoimmune disease, vascular leakage syndrome, inflammatory disease, edema, transplant rejection, bum, or acute respiratory distress syndrome (ARDS)), wherein each of A is independently selected from a group consisting of C, CH, N, and a part of a ring fusion to form a second ring, where the second ring is an aromatic, a heteroaromatic, a bicyclic aromatic, a bicyclic aromatic heterocyclic ring, or a bicyclic with only the first ring being aromatic or heteroaromatic; each of B is independently selected from a group consisting of C, CH, N, and a part of a ring fusion to form a second ring, where the second ring is an aromatic, a heteroaromatic, a bicyclic aromatic, a bicyclic aromatic heterocyclic ring, or a bicyclic with only the first ring being aromatic or heteroaromatic; and wherein the other substituents are as defined herein.
Patent NZ-551146-A (NZ)
Title: Desulphatohirudin for treating prevascularised metastasised tumors
Inventor: YU CHENG-DER TONY
IPC: A61K38/54
Filed: 2005-04-05
Abstract: Disclosed is the use of a formulation comprising an effective amount of desulphatohirudin or a functional desulphatohirudin variant in the manufacture of a medicament formulated for treating prevascularised metastasised tumour to effect regression of the tumour.
Patent NZ-560813-A (NZ)
Title: A composition for creating an artificial bone-marrow like environment and use thereof
Inventor: KALE VAIJAYANTI PRAKASH
IPC: C12N5/071
Filed: 2005-07-22
Abstract: Provided is a composition useful in developing an Artificial Bone Marrow-like Environment (ABME) for modulating several aspects of Stem and Progenitor Cell (SPC)-functions and bone marrow processes, comprising: a] a culture of mesenchymal cells; b] a hematopoietic modulator, or plurality of modulators, capable of activating intracellular signaling in the cells of step 1a; wherein the hematopoietic modulator(s) is(are) selected from any of: a biological agent , a chemical agent , or an immunological agent and one or more combinations thereof; c] a culture medium selected from Iscove's Modified Dulbecco's Medium (IMDM), Dulbecco's modified Eagle's medium (DMEM), Alpha-Minimum essential medium (á-MEM), RPMI-1640 that is supplemented with: i) suitable serum or suitable serum substitute; and ii) optionally supplemented with : hematomodulators that promote hypoxic state in the cells of claim 1a, methyl cellulose, hematopoietic growth and differentiation factors, erythropoietin, stem cell factor (SCF), Interleukin- 1beta, Interleukin- 3 and Interleukin- 6; and d] a support for the cells of claim 1a comprising constituents of extra cellular matrix, or their mimetics, capable of forming a matrix in two or more dimensions. Further provided are methods and kits for making the composition.
Patent NZ-563944-A (NZ)
Title: Dental mineralization with a protein disrupting agent in combination with stabilised amorphous calcium phosphate (ACP) and / or amorphous calcium fluoride phosphate (ACFP)
Inventor: REYNOLDS ERIC CHARLES
IPC: A61K8/20
Filed: 2006-06-07
Abstract: Disclosed is the use of a protein disrupting agent (such as a bleach (sodium hypochlorite or a carbamide peroxide bleach for example), a detergent, a chaotropic agent, a protease or a mixture of proteases) in the manufacture of a first composition and use of stabilised amorphous calcium phosphate (ACP) or amorphous calcium fluoride phosphate (ACFP) in the manufacture of a second composition, the first and second compositions being used to mineralise a dental enamel, wherein the first composition is applied to the dental enamel prior to the second composition. Also disclosed is a kit for the treatment or prevention of one or more of dental caries, fluorosis and dental erosion including (a) a protein disrupting agent and (b) casein phosphopeptide (CPP) stabilised amorphous calcium phosphate (ACP) and/or CPP stabilised amorphous calcium fluoride phosphate (ACFP) in a pharmaceutically acceptable carrier.
Patent NZ-566428-A (NZ)
Title: Thiomorpholine compound and process for preparing the same
Inventor: TAKAHASHI MASAMI
IPC: A61K31/541
Filed: 2006-09-01
Abstract: The disclosure relates to a thiomorpholine compound represented by the formula [I]: wherein Ring A represents an optionally substituted benzene ring; Ring B represents an optionally substituted benzene ring; R1 represents hydrogen atom, an optionally substituted hydroxyl group, an optionally substituted amino group, an optionally substituted alkyl group, a substituted carbonyl group or a halogen atom; R2 represents hydrogen atom or an optionally substituted alkyl group; R3a and R3b may be the same or different from each other, and each represent hydrogen atom or an optionally substituted alkyl group, or combined to each other at the both ends thereof to form an alkylene group, and n is an integer of 1 or 2, or a pharmaceutically acceptable salt thereof. Also disclosed is a process for preparing said thiomorpholine compound, a pharmaceutical composition comprising of said compound and the use of the compound in the manufacture of a medicament for the treatment and prophylaxis of a disease selected from inflammation, allergies, pain, migraine, neuralgia, itchiness, cough, central nervous system diseases digestive organs disease nausea, emesis, urinary disorder, circulatory disease and immune disorder.